Cubist Systematic Strategies’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-505,206
| Closed | -$5.12M | – | 3128 |
|
|
2023
Q1 | $5.12M | Sell |
505,206
-10,400
| -2% | -$105K | 0.03% | 589 |
|
|
2022
Q4 | $5.13M | Buy |
515,606
+7,943
| +2% | +$79K | 0.03% | 674 |
|
|
2022
Q3 | $4.95M | Buy |
507,663
+7,196
| +1% | +$70.2K | 0.03% | 832 |
|
|
2022
Q2 | $4.86M | Buy |
500,467
+332,492
| +198% | +$3.23M | 0.03% | 839 |
|
|
2022
Q1 | $1.63M | Sell |
167,975
-6,530
| -4% | -$63.3K | 0.01% | 1658 |
|
|
2021
Q4 | $1.69M | Buy |
+174,505
| New | +$1.69M | 0.02% | 1516 |
|